Expert analyst Patrick Trucchio has spent many years researching the psychedelic drug stock sector. Patrick Trucchio, CFA, is a Managing Director of Equity Research at H.C. Wainwright & Co. whose ...

Let’s start with a brief overview and history of the company. Dr. Marques: Of course. Pasithea Therapeutics is a company that has been founded with the objective to develop novel therapies, or best-in ...

So, it’s been a few years since you last spoke with The Wall Street Transcript. Let’s start with a refresher about the company and its history and how it’s evolved over the years. Mr. Groesbeck: I’ll ...

Let’s start with a brief history of the company and its focus on accessories for cannabis. Ms. Sher: Sure. So Greenlane is the leading global omnichannel platform for the development and distribution ...

Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF) Ahmad Doroudian Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF) Robert Beasley Interview with the CEO: Greenlane Holdings ...

Please introduce your firm, your role, and what you cover in terms of the psychedelics market. Mr. Trucchio: I work at H.C. Wainwright, an investment bank headquartered in New York, as a senior health ...

Let’s start with a brief overview of the company, including some major milestones. Mr. Beasley: Cansortium is a publicly traded company, which is a Canadian registered entity on the Ontario Exchange.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.